Procter & Gamble Health Limited (NSE:PGHL)

Procter & Gamble Health Income Statement

Financials in millions INR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Operating Revenue	12,181	11,513	12,296	11,144	10,087	8,886
Revenue	12,181	11,513	12,296	11,144	10,087	8,886
Revenue Growth (YoY)	4.23%	-6.37%	10.34%	10.48%	13.52%	-4.10%
Cost of Revenue	3,537	3,425	3,834	3,531	3,245	3,206
Gross Profit	8,644	8,087	8,463	7,614	6,842	5,680
Selling, General & Admin	2,437	2,682	2,811	2,776	2,421	2,460
Other Operating Expenses	2,535	2,340	2,412	2,141	1,943	1,111
Operating Expenses	5,211	5,296	5,504	5,188	4,669	3,789
Operating Income	3,433	2,791	2,959	2,426	2,173	1,892
Interest Expense	-6.3	-7.2	-7.7	-4.2	-8	-
Interest & Investment Income	117.3	117.3	143.3	110.7	150.6	572.5
Currency Exchange Gain (Loss)	2.7	2.7	3.4	-6.9	-8.9	26.7
Other Non Operating Income (Expenses)	4.8	36.3	30.1	21.2	30.4	-283.96
EBT Excluding Unusual Items	3,552	2,940	3,128	2,546	2,337	2,207
Gain (Loss) on Sale of Assets	-5.1	-5.1	7.1	-5.4	-4.2	-32.5
Asset Writedown	-201.9	-201.9	7.3	-7.3	-	-
Other Unusual Items	-	-	-	-	-	24.2
Pretax Income	3,345	2,733	3,142	2,534	2,333	2,199
Income Tax Expense	832.6	723.4	847.3	608.5	564.8	539.42
Earnings From Continuing Operations	2,512	2,010	2,295	1,925	1,768	1,659
Net Income	2,512	2,010	2,295	1,925	1,768	1,659
Net Income to Common	2,512	2,010	2,295	1,925	1,768	1,659
Net Income Growth	17.37%	-12.42%	19.19%	8.89%	6.56%	4.51%
Shares Outstanding (Basic)	17	17	17	17	17	17
Shares Outstanding (Diluted)	17	17	17	17	17	17
Shares Change (YoY)	0.01%	-	-	-	-0.08%	0.08%
EPS (Basic)	151.33	121.08	138.24	115.98	106.51	99.87
EPS (Diluted)	151.25	121.00	138.00	115.98	106.51	99.81
EPS Growth	17.52%	-12.32%	18.99%	8.89%	6.72%	4.35%
Free Cash Flow	-	2,066	1,935	1,316	1,947	1,414
Free Cash Flow Per Share	-	124.44	116.58	79.28	117.28	85.11
Dividend Per Share	185.000	110.000	95.000	52.500	40.000	28.000
Dividend Growth	85.00%	15.79%	80.95%	31.25%	42.86%	16.67%
Gross Margin	70.97%	70.25%	68.82%	68.32%	67.83%	63.92%
Operating Margin	28.18%	24.24%	24.06%	21.77%	21.54%	21.29%
Profit Margin	20.62%	17.46%	18.66%	17.28%	17.53%	18.67%
Free Cash Flow Margin	-	17.94%	15.74%	11.81%	19.30%	15.91%
EBITDA	3,671	3,034	3,188	2,648	2,424	2,088
EBITDA Margin	30.14%	26.36%	25.92%	23.76%	24.03%	23.50%
D&A For EBITDA	238.15	243	229	222.1	251.1	196.33
EBIT	3,433	2,791	2,959	2,426	2,173	1,892
EBIT Margin	28.18%	24.24%	24.06%	21.77%	21.54%	21.29%
Effective Tax Rate	24.89%	26.47%	26.97%	24.02%	24.21%	24.54%
Revenue as Reported	12,305	11,669	2,480	11,276	10,268	9,225
Advertising Expenses	-	526.5	744.9	1,095	874.1	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.